drugset / Trial / NCT02045238

Inhaled Hypertonic Saline Use in the Emergency Department to Treat Acute Viral Bronchiolitis

NCT02045238

Terminated 32 enrolled University of Sao Paulo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Acute viral bronchiolitis is an extremely common childhood disease, responsible for approximately 17% of childhood admissions to hospital per year, with an annually cost that reaches U$ 500 million. Despite being a well known disease among pediatricians, there are few, if any, effective treatment options apart from oxygen supplementation and adequate hydration. The purpose of this study is to determine wether nebulized hypertonic saline (3%) is more effective than normal saline (0,9%) when used in repeated doses during the first 24 hours of in-hospital treatment.

Timeline

Start
2013-07
Primary completion
2014-12
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 3 % Inhaled

Indications